323 related articles for article (PubMed ID: 24747945)
1. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
3. Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.
Qin Q; Qu C; Niu T; Zang H; Qi L; Lyu L; Wang X; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
Hypertension; 2016 Jan; 67(1):107-17. PubMed ID: 26573705
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
6. Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.
Dludla PV; Muller CJ; Joubert E; Louw J; Essop MF; Gabuza KB; Ghoor S; Huisamen B; Johnson R
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098811
[TBL] [Abstract][Full Text] [Related]
7. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
Xing Y; Niu T; Wang W; Li J; Li S; Janicki JS; Ruiz S; Meyer CJ; Wang XL; Tang D; Zhao Y; Cui T
PLoS One; 2012; 7(9):e44899. PubMed ID: 23028668
[TBL] [Abstract][Full Text] [Related]
8. CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.
Qi L; Zang H; Wu W; Nagarkatti P; Nagarkatti M; Liu Q; Robbins J; Wang X; Cui T
J Mol Cell Cardiol; 2020 Aug; 145():59-73. PubMed ID: 32553594
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress.
Kumar RR; Narasimhan M; Shanmugam G; Hong J; Devarajan A; Palaniappan S; Zhang J; Halade GV; Darley-Usmar VM; Hoidal JR; Rajasekaran NS
J Transl Med; 2016 Apr; 14():86. PubMed ID: 27048381
[TBL] [Abstract][Full Text] [Related]
10. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
12. Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.
Zhang Y; Cui Y; Dai S; Deng W; Wang H; Qin W; Yang H; Liu H; Yue J; Wu D; Wang J; Guo H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):203-212. PubMed ID: 31489470
[TBL] [Abstract][Full Text] [Related]
13. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
[TBL] [Abstract][Full Text] [Related]
14. Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.
Guo Y; Li D; Cen XF; Qiu HL; Ma YL; Liu Y; Huang SH; Liu LB; Xu M; Tang QZ
Oxid Med Cell Longev; 2022; 2022():8367997. PubMed ID: 35242278
[TBL] [Abstract][Full Text] [Related]
15. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
[TBL] [Abstract][Full Text] [Related]
16. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
[TBL] [Abstract][Full Text] [Related]
18. RNF13 protects against pathological cardiac hypertrophy through p62-NRF2 pathway.
Guo S; Zhang BB; Gao L; Yu XY; Shen JH; Yang F; Zhang WC; Jin YG; Li G; Wang YG; Han ZY; Liu Y
Free Radic Biol Med; 2023 Nov; 209(Pt 2):252-264. PubMed ID: 37852547
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
[TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
